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Abstract
Background: The introduction of Patient Group Directions (PGD) has changed significantly the way in which nurses can now
administer prescription only medicines as a one-off for patients requiring this level of service. PGD’s are a written authority to
administer drugs to patients that are not identified at the time of treatment.
Aim: The aim of this project was to develop a PGD for use within an Outreach team to administer colloid boluses to patients
presenting with hypovolemia.
Method: Using a case exemplar this paper will discuss the development of a PGD using aspects of transitional change theory
to highlight the potential barriers that were encountered.
Implications for Practice: The implications for this PGD are wide reaching. First it now enables members from the nursing
Outreach team to administer colloid fluid boluses to a prescribed patient cohort without the need for prescription. Second, it
ensures the deteriorating patient has interventions initiated in a timely and appropriate manner to reduce inadvertent admission
to high care areas. Last, it will improve inter-professional team-working and communication so much so that collaborative
patient care reduces health costs and identifies earlier those patients requiring substantially greater nursing and medical input.
Conclusion: The experience of developing a working PGD for fluid administration has meant that the Outreach team is able to
respond to patients in a more effective way. In addition, it is the experience of developing this PGD that has enabled the team to
contemplate other PGD’s in the execution of Outreach work.
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1 Introduction
With the inception of Outreach, unwarranted or inappropri-
ate admissions to the Intensive Care Unit (ICU) have seen
a dramatic decrease leaving these valuable beds to those
patients who require this form of specialised nursing and
medical care. Outreach to the uninitiated is a group of spe-
cially trained ICU nurses that provide expert nursing care,
education and assistance to patients, fellow nurses and doc-
tors in general ward environments. Developed as a result of
the United Kingdom’s (UK) Department of Health (DoH)
Comprehensive Critical Care[1] white paper, Outreach teams
have become important in detecting and managing the de-
teriorating patient. In addition, Outreach teams are well
placed to support those patients discharged to the ward from
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high care areas, such as the ICU, so that these patients are
treated and managed in a more timely and appropriate man-
ner and thus prevent unnecessary ICU readmission. De-
spite, having expert physical assessment and communica-
tion skills, the Outreach team are hampered by their level of
responsibility within the health professional team in terms
of drug and fluid administration. Using a patient case ex-
emplar this paper will explore and reflect upon the process
of developing and writing a Patient Group Direction (PGD).
In particular it will identify the rationale as to the need for
a PGD, in this instance combining with this the underlin-
ing pathophysiology and pharmacology inherent in its de-
velopment. It will also give consideration to the legal, ethi-
cal and professional issues involved in the administration of
prescription only medicines and finally give thought to the
implications for practice.
1.1 Patient case exemplar
Mrs Jones (not her real name to protect confidentiality), was
admitted for elective surgery for the freeing of abdominal
adhesions. Her surgery and subsequent short term recov-
ery were uneventful. However, day two post-operatively
her vital signs had changed significantly. An Outreach re-
view was requested by the nurse caring for Mrs Jones, ask-
ing for an evaluation of her current condition and to sup-
port the junior doctor as the latter was unsure what to do.
Obtaining a brief handover from Mrs Jones’ nurse, it was
reported that her current blood pressure was 85-90mmHg
systolic and had been for the last 4 hours. It had also been
reported the her urine output had “tailed off” to less than the
recommended 12ml/kg/hour
[2] and that her total urine out-
put for the last six hours was 70 millilitres. The Outreach
nurse’s immediate impression of her was someone who was
tachypneic, pale and clammy. Closer examination revealed
that she had a heart rate of 110 beats per minute with no
ectopy, a blood pressure (BP) of 91/34, a non-discernable
jugular venous pressure (JVP), and a capillary refill time of
more than three seconds. She also had a non-monitored cen-
tral venous pressure (CVP) line. Mrs Jones also appeared to
have lower limb pitting oedema which needed assessment to
ascertain if this was due to heart failure or as a result of the
surgery. Her previous medical history revealed no cardiac
problems and in view of the fact that her JVP and diastolic
were low it was decided this was a fluid deficit problem. To
confirm this, the Outreach nurse set up a fluid manometer
to measure her CVP to find the reading being 3cms/H2O.
It was evident from her prescription chart that Mrs Jones
had received 4 litres of crystalloid intravenous (IV) fluids
since her return from theatre; the current infusion being one
litre of 5% dextrose running over 8 hours. Yet, it would
appear that the fluid given was simply ‘third-spacing’ (in-
terstitial space fluid trapping) which was probably height-
ened by a systemic inflammatory response from the recent
surgery. Indeed her lab work confirmed this with a ‘nor-
mal’ serum sodium in that the hypovolemia wasn’t as a re-
sult of fluid depletion. Therefore what she needed was a
fluid challenge, such as could be done with Gelofusine – an
iso-oncotic gelatine solution,[3] that would draw fluid back
into the intravascular space and improve her BP. The junior
doctor was approached and after conveying their assessment
findings the Outreach nurse suggested that Mrs Jones be ad-
ministered 500 mls of Gelofusine over an hour to see if it
would improve her BP. This being a new rotation, the doc-
tor was rather reluctant to prescribe the Gelofusine because
she was unfamiliar with its use and instead opted for an-
other bag of crystalloid this time 0.9% saline until she could
confer with her registrar.
The case study highlighted above prompted discussion
amongst Outreach nursing colleagues that we were finding
it increasingly frustrating not being able to provide a fully
rounded Outreach service.[4] One key aspect of this was not
being able to administer IV fluids without first having it pre-
scribed because of restrictions for nurses to prescribe under
the Medicines Act 1968.[5] This was even more frustrat-
ing despite the fact that we had all attended the Acute Life
Threatening Events Recognition and Treatment (ALERT)
course which advocates in certain conditions the adminis-
tration of crystalloid or colloid fluids. Therefore, as a result
we were reliant on medical staff to prescribe the necessary
IV fluids for our patients, which was not always possible
in busy ward environments. As a team it was evident we
needed to be able to administer colloids legally without the
need of a prescription, save all of us attending a nationally
recognised nurse prescribing course.
1.2 Background to the Inception of PGD’s
Nurse prescribing in the UK has now been given the right to
prescribe from the entire British National Formulary (BNF)
– a pharmaceutical reference used by health professionals
which provides advice on medicinal prescribing and phar-
macology. Prior to this nurse’s were only able to pre-
scribe a limited formulary as deemed appropriate by the
Cumberledge[6] and Crown Reports.[7] It was these reports
that led to limited prescribing with the introduction of the
Medicinal Products: Prescriptions by Nurses Act[8] which
saw designated district nurses and health visitors being able
to prescribe wound dressings and drugs available on general
sale lists. 1994 saw the first Nurse Prescriber’s Formulary;
however it was the second Crown Report[9] that heralded
the introduction of Patient Group Directions (PGD’s). Fi-
nal amendments to the report not only identified new cate-
gories of prescriber’s but together with the National Health
Service Executive Health Service Circular[10] were guide-
lines for PGD use and implementation acknowledged. This
meant that there now existed a legal framework for which
nurses could prescribe albeit limitedly. By definition, PGD’s
are written instructions that allow for the supply, sale and
administration of named medicines to individuals that are
unidentified at the time of treatment for a specific clinical
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situation without the need for a prescription.[11–14]
PGD’s are currently used in a wide arena of care delivery sit-
uations – from midwifery practice[15] to mental health nurs-
ing.[16] It appears from the literature that their main use is in
the emergency department[17] or community practices where
“one off” drug dispensing is seen as more appropriate in cer-
tain situations, for example the administration of the morn-
ing after contraceptive pill or the influenza vaccine. Need-
less to say the development of PGD’s has to some degree
enable nurses to administer prescription only medicines in
situations of necessity.[18] However, the acceptance of us-
ing PGD’s in the acute setting has not been forthcoming as
would be expected.
1.3 Identifying the need for a PGD in fluid admin-
istration
In the situation described in the case exemplar, PGD’s could
be very useful when meeting the needs of patients that re-
quire immediate action as would be seen with an Outreach
referral. The legal framework to be able to prescribe and
administer Gelofusine in the form of a PGD, then allowed
us to start developing a PGD for fluid administration. It
was common knowledge that the Accident and Emergency
(A&E) department were using PGD’s to administer certain
medicines to patients that required a one-off treatment such
as the morning after pill, so it was a case of networking and
liaising with those key individuals as to how to proceed. Ini-
tial meetings with the PGD development team from A&E
identified that the hospital had an already recognised pro-
forma which meant that the legal authorisation was already
established. However, we were mindful of the work under-
taken by Robson et al.[19] in developing a PGD for fluid
management in an orthopaedic ward for post-operative hy-
potension. They experienced the same problems as we had
in accessing medical staff to review and prescribe fluids. In
order to demonstrate success of the PGD, a pilot study of 14
patients who met the inclusion criteria (major joint replace-
ment surgery) were administered 500mls of 0.9% normal
saline fluid boluses for hypotension. 95% of patients re-
sponded favourably to the boluses with significant increases
in blood pressure in addition to suffering no complications
as a result of these fluid boluses. This study also found the
mean rise in blood pressure was 18.7mmHg after the first
fluid bolus with another 3% rise following a second fluid
challenge (p < .001). Based on pilot study results we were
able to support our need for a fluid PGD and as such it was
a case of preliminary filling in the key features of the doc-
ument in collaboration with the ICU pharmacist. Included
in the documentation were the drug details, the clinical con-
dition related to the use of Gelofusine, staff characteristics,
hospital authorisation and subsequent arrangements for re-
ferral before submitting the draft for approval from the clin-
ical governance committee.
Gelofusine
Gelofusine is a collagen based synthetic plasma volume ex-
pander[3] made by the succinylation of gelatine and works
by increasing the plasma colloid osmotic pressure. It has a
molecular weight of 35,000 Daltons which means it has a
similar molecular structure to that of human albumin and
also as a result of the succinylation process has a nega-
tive charge which prevents leakage into the interstitial space
and aids effective colloid osmotic pressure through the Don-
nan Equilibrium effect.[20, 21] Normal colloid osmotic pres-
sure (normal pressure being 28mmHg) is maintained within
the intravascular space because of dissolved plasma pro-
teins namely albumin. Albumin exerts its osmotic effect
not so much by its molecular mass but by the number of
molecules present – in essence setting up a solute concen-
tration gradient between the intravascular and interstitial
spaces.[20] However, this alone does not solely contribute
to the movement of water. The Donnan Equilibrium ef-
fect adds a further 50% to the ‘osmotic pull’ with the use
of sodium. Because of its negative charge, albumin attracts
a sodium molecule near to it to maintain electrical neutral-
ity, therefore the presence of the sodium molecule further
increases the movement of water. Gelofusine acts in exactly
the same way because of its negative charge and the number
of molecules present within the intravascular space.[20]
Gelofusine is effective in a variety of conditions that re-
quire fluid resuscitation, for example, burns, hypovolemic
shock, sepsis and haemorrhage.[21] It is well tolerated and
has no risk in the development of hyperchloremic acidosis.
It should be used with caution in known hypersensitivity to
Gelofusine as well as hypervolemia, severe cardiac insuf-
ficiency, renal impairment[3] and because of the amount of
sodium present (154mmols/litire) and hypernatremia. Gelo-
fusine can, because of its osmotic effect, dilute the coagula-
tion factors.[3] However, it has also been linked with causing
a coagulopathy because of its action on the cross linking of
fibrin strands. Collagen in isolation can have a profound ef-
fect on the coagulation system; therefore collagen based col-
loids will exert the same effect however at a cellular level.
The problem is that the conventional coagulation screen of
APTT and INR are measuring clot formation at the throm-
bin stage. The effects of Gelofusine occur at the cellular
stage which is after thrombin formation and as a result clot
stability is not guaranteed.[22, 23]
2 Reflecting on future practice
Reflecting on the empirical knowledge[24] central to and
used throughout the PGD development process, we con-
cluded that reviewing the background pharmacology and
completing the trusts pro-forma was integral in applying
the pathophysiological principles of this clinical situation.
We believed that the addition of this PGD to our current
practice would demonstrate effective clinical reasoning as
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well as professional accountability in action.[25] Moreover,
it meant that patients no longer had to wait for the appro-
priate care to be provided and as a consequence their care
was streamlined by ensuring that they receive the right care,
at the right time and by the right person.[26, 27] However,
we were always drawn back to the legal and ethical do-
main that governs their practice, ever mindful of the chal-
lenges to prove high levels of knowledge and competence
as well as the professional considerations especially when
using PGD’s.[28, 29] For example those rooted in the nursing
Code of Professional Conduct[30] together with the Guide-
lines for the Administration of Medicines[31] and the Royal
College of Nursing’s[25] guidance for the use of PGD’s. Yet
when we compared this with our own individual personal
knowledge[24] we realised that experience and knowledge-
able know-how, the technical-rationale paradigm,[32] are not
enough to ensure safe practice and the adherence to pro-
fessional codes especially where the administration and the
prescribing of prescription drugs are concerned. Indeed,
this further reinforced aesthetically[24] the way that we were
able to identify the subtleties present in this patients con-
dition that prompted our initial diagnosis, that tacit under-
pinning and recognition, articulation and integration of the
whole.[24]
Developing the PGD
The initial difficulties in developing this PGD was the prob-
lem posed with having to liaise with so many specialty
medical staff because of the sheer number of wards that
Outreach had to cover. Trying to gain a consensus as to
which patient groups, based on their particular consultant,
this PGD would apply was almost impossible. The team
was disappointed that it almost seemed that the idea was
quashed before it started. Therefore our first step was to
construct a domainal map of stakeholder influence so that
the key people could be approached which could then create
an open dialogue about our PGD’s advantages and benefits
to patient care (see Table 1).
Table 1: Domainal Map of Stakeholders[33]
 
 
Stakeholders: Ward Nursing Staff Outreach Nursing Staff Medical Staff 
Present 
Involvement: 
 Uncertainty of care required  Hampered by care required  Overall responsibility for 
patient care activities 
Future Benefit: 
 Sense of involvement and 
inclusivity  
 Continuity of care 
 Increased knowledge  
 Increased physical assessment 
skills 
 Better inter-professional 
communication  
 Initiate appropriate treatment 
 More patient contact,  
 Direct and plan effective ward 
based nursing care,  
 Increased skills in teaching and 
assessment. 
 Collaborative partnership in 
the provision of care 
 More effective coordinated 
services 
Potential Costs: 
 Increased assessment 
 Inappropriate referrals to 
Outreach 
 Increased clinical responsibilities 
 Preference for status quo 
 Loss of patient contact 
decreased job satisfaction, and 




 Resort to original patterns of 
nursing care. 
 Ineffective inter-professional 
communication,  
 Resort to original patterns of 
nursing care. 
 Lack of trust,  
 Interfere with planned care. 
 
The work of Christensen and Christensen[34] (2007) was in-
tegral in developing our domainal map as well as giving us
insight into the process of transitional change theory. There-
fore we also included in our PGD development a force field
analysis[35] to serve as an adjunct to identifying the driving
and resisting forces (see Table 2). We were fortunate enough
to get support from the ICU consultants who were instru-
mental in mediating with medical colleagues under the guise
that if patients were referred to Outreach then the ICU con-
sultant ‘on-call’ for Outreach would be actively involved,
collaboratively, in prescribing care. As such the need to con-
fer with different medical teams was by and large dealt with
by the ICU consultants and we were able to ‘get-on’ with
the job at hand. However, following completion of the pro-
forma, the time taken for approval was lengthy because of
various amendments that needed to be rectified. The clinical
governance team were meticulous in their appraisal of the
PGD to the point that we felt that they were being too overly
cautious without due consideration of those who would be
applying the PGD. It was at this point that we nearly gave
into perceived “gate-keeper” challenges because of what ap-
peared to be unnecessary changes to our PGD. Yet in ret-
rospect we could understand the governance teams caution
and perhaps if we had identified prior to submission the po-
tential challenges that we would have to face we could have
planned better allowing a more amenable acceptance of our
PGD, similar in some respects to that identified by our force
field analysis (see Table 2).
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Table 2: Force-Field Analysis of PGD Development[35]
 
 
Driving Forces  Restraining Forces 
 ↑ continuity of care, skills and physical assessment. 
 ↑ staff confidence 
 Improved professional accountability 
 Effective individualised patient focused care 
 Adherence and implementation of DoH guidelines 
 ↓ frustration 
 ↑ inter-professional team-working 
 Adherence to clinical governance principle’s 
 Timely patient intervention 
EQUALIBRIUM 
 Fear of change 
 ↑ nursing responsibility 
 ↑ nursing accountability 
 Maintenance of current situation 
 ↑ physical assessment 
 ↑ nursing and medical workload 
 Sporacity of patient group 
 Ineffective or obstructive medical input 
 






 Hypotension and /or oliguria 
 Evidence of poor perfusion (capillary refill time (CRT) greater than 3 seconds. 
Inclusion criteria 
Patients with:  
 Hypotension – systolic blood pressure (BP) 80-100mmHg. 
 Oliguria – urine output less than ½ml/kg/hr for at least 2 hours. 
 Capillary refill greater than 3 seconds. 
Exclusion criteria 
 Avoid in anaphylaxis. 
 Known sensitivity to Gelofusine. 
Cautions/Need for further advice  Patients exhibiting signs of cardiac failure, fluid overload, anaphylaxis. 
Action if patient declines or is excluded 
 Urgent referral to senior member of patient’s medical team or critical care medical staff.
 Document in patient’s notes. 
 Give 1 litre Normal Saline 0.9% in anaphylaxis (according to PGD). 
DRUG DETAILS 
Pharmaceutical Details 
‐ Name: Gelofusine 
‐ Form (tablet/mixture/injection etc.): Intravenous Infusion 
‐ Strength: 4% 
Route(s)/Method(s) of administration Intravenous administration via peripheral or central line 
Dosage 
 500-1000mls to be administered over 10minutes to 1 hour depending on patient’s 
condition and response to treatment. 
 200mls only if cardiogenic shock is suspected 
Frequency Maximum of 1 litre prior to each individual medical review. 
Duration of treatment Up to 1 hour. 
OR Maximum or minimum treatment period As above. 
Quantity to be supplied/administered Up to 1 litre. 
Side effects Anaphylaxis, increase in bleeding time (transient). 
Advice to patient/carer 
 Explanation of reasons for fluid administration. 
 Acceptable limits of blood pressure (BP), pulse (P), urine output (UOP) and capillary 
refill time (CRT). 
 Minimum monitoring requirements – CRT, P, BP, UOP. 
Follow-up Urgent senior medical review regarding further fluid requirements and investigations. 
STAFF CHARACTERISTICS 
Qualifications  Registered Nurse RGN, RN(Adult) 
Specialist competencies or qualifications 
 Minimum of 2 years’ experience at senior nursing level (Grade Band 5 or above). 
 Acute Life Threatening Events Recognition and Treatment (ALERT) course 
 Relevant critical care post-registration course e.g. Advanced Life Support, Physical 
Assessment, ENB 100. 
Continuing training & education 
 Annual life support update 
 Participation in ALERT course 
Note. ENB= English National Board – a national UK accrediting authority for post-registration specialisation courses, in this case the ENB 100 is the Intensive Care Nursing 
Course. 
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If the production of this PGD had not been undertaken then
the consequences for patient care would be insurmountable,
similar to those experienced by Robson et al.[19] Past expe-
riences and data from the ongoing clinical audit of Outreach
referrals of patients being admitted to ICU with acute fluid
overload, hypovolemic shock, acute renal failure and acute
respiratory failure secondary to pulmonary oedema are tes-
tament to the unstructured and inappropriate way that fluid
management in the ward environment can sometimes occur.
In some cases we felt helpless to intervene with admission
to ICU the only available option. In our opinion the PGD
for Gelofusine was a positive step forward if for anything to
bring some uniformity to the way patients were cared for in
terms of their fluid management (see Table 3).
3 Implications for practice
The introduction of a PGD for Gelofusine has improved the
care the Outreach team can now provide. In the past we
were reliant on medical decision-making which often meant
delays in initiating treatment and in some cases inadvertent
admission to the ICU for fluid management. This PGD has
expanded, enlightened and re-examined the Outreach team’s
knowledge and ways of knowing and working. Firstly, it has
expanded our personal knowledge not only of fluid man-
agement but also the legal and ethical premises that are in-
volved in developing PGD’s and the team’s obligations and
accountability whilst using them. Secondly it has stressed
the importance of thoroughness and diligence in utilising
the skills of conducting a physical examination especially
of the cardio-respiratory system. Lastly, it has helped bridge
the inter-professional relationships that we have with other
health care professionals and as such will contribute to bet-
ter future working relationships.
4 Conclusion
The process of developing a PGD for Gelofusine for use
within the Outreach team was a rewarding experience. The
current version is undergoing review in light of the changes
to independent nursing prescribing[36, 37] in the UK and the
way in which PGD’s are used and developed. Whilst it is
worthwhile acknowledging that this will contribute to an im-
provement in patient care, it is the innovative advancement
in enhancing evidenced-based individualised patient centred
care as well as reducing unnecessary admissions to ICU that
matters as well.
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